Search
News
Ultragenyx Q2 2026 earnings: Record revenue narrows the operating loss
Ultragenyx reported second-quarter 2026 revenue of $214 million, up about 28% year over year and the highest quarterly total in company history. Net loss narrowed to $92 million from $115 million, while net loss per share improved to $0.90 from $1.17. Crysvita generated $156 million and remained the main growth driver. The company ended June with $436 million in cash, equivalents and marketable securities, used $97 million in operating cash during the quarter, and reaffirmed full-year revenue guidance of $730 million to $760 million ahead of two FDA decision dates and a Phase 3 readout.
TradingKey
Wed, Aug 5
Kratos Q2 2026 Earnings: 30.5% Revenue Growth Comes With an Operating Loss
Kratos Defense & Security Solutions' Q2 2026 revenue rose 30.5% to $458.8 million, including 19.1% organic growth, while GAAP diluted EPS remained $0.02. Adjusted EBITDA increased to $38.2 million, but the company posted a $1.6 million operating loss and used $11.0 million of operating cash as working capital and production investments rose. KGS led growth, consolidated backlog reached $2.084 billion, and Kratos raised full-year revenue guidance to $1.75 billion-$1.81 billion while forecasting continued free-cash-flow use.
TradingKey
Wed, Aug 5
Archrock Q2 2026 earnings: Contract compression offsets aftermarket weakness
Archrock’s Q2 2026 revenue fell 3.1% year over year to $371.2 million, while GAAP diluted EPS rose to $0.38 from $0.36. Contract operations revenue increased 3% and its adjusted gross margin reached 71%, but aftermarket services revenue dropped to $42.0 million as parts sales and major-maintenance demand weakened. Adjusted EBITDA was nearly unchanged at $212.6 million. Archrock narrowed full-year adjusted EBITDA guidance to $865 million-$885 million, citing make-ready costs, lube oil pressure, softer aftermarket demand and higher SG&A, while reaffirming 2026 growth capital spending.
TradingKey
Wed, Aug 5
AMD Q2 2026 earnings: Data Center revenue more than doubles
AMD’s Q2 2026 revenue rose 50% year over year to $11.536 billion, while GAAP diluted EPS increased to $1.38 from $0.54. Data Center revenue more than doubled to $6.718 billion and accounted for 58% of company sales, supported by demand for EPYC processors and Instinct GPUs. Profitability also improved, although the year-over-year margin comparison benefited from $800 million of export-control-related inventory and associated charges recorded in Q2 2025. Management expects Data Center sales growth to accelerate in the second half of 2026.
TradingKey
Wed, Aug 5
Palomar Q2 2026 earnings: Premium growth offsets a higher loss ratio
Palomar Holdings’ Q2 2026 total revenue rose about 54.6% to $314.4 million, while diluted EPS increased to $1.94 from $1.68. Gross written premiums grew 27.0% to $630.5 million and adjusted net income advanced 31.4% to $63.8 million. However, the loss ratio increased to 34.5% and the combined ratio worsened to 83.3% as losses rose faster than earned premiums. Casualty, Crop, and Surety & Credit drove premium growth, and Palomar raised full-year adjusted net income guidance to $270 million-$280 million. The quarter also brought an initial dividend.
TradingKey
Wed, Aug 5
AGNT Q2 2026 Earnings: Record Revenue and Adjusted EBITDA More Than Doubles
AGNT Inc. reported Q2 2026 revenue of $1.45 billion, up 11% year over year, while diluted loss per share widened to $0.02 from $0.01. Adjusted EBITDA rose 129% to $25.7 million as operating expenses increased only 2%, helping the company return to positive operating income despite a lower gross margin. Real estate transactions increased 12% and sales volume grew 15%. AGNT also issued Q3 revenue guidance of $1.35 billion to $1.45 billion and narrowed full-year adjusted EBITDA guidance to $50 million to $60 million.
TradingKey
Wed, Aug 5
Okeanis Eco Tankers Q2 2026 earnings: Profit rises to $230.3 million
Okeanis Eco Tankers (ECO) reported Q2 2026 revenue of $318.9 million, up from $93.9 million a year earlier, while profit increased to $230.3 million and EPS reached $5.90. Profit grew much faster than vessel operating expenses, and VLCCs recorded the fleet’s highest Q2 daily TCE rate. Investors’ next focus is the partially booked Q3 spot program, where booked Suezmax rates are running below the Q2 level, alongside the company’s substantial dividend distribution.TradingKey
Wed, Aug 5
Stride Fiscal Q4 2026 Earnings: Revenue Falls as Adjusted Profit Weakens
Stride’s fiscal fourth-quarter 2026 revenue fell 2.7% to $636.1 million as a 9.7% decline in General Education outweighed 8.0% growth in Career Learning. GAAP diluted EPS rose 69.9% to $1.75, but the increase largely reflected the absence of a $59.5 million prior-year impairment; adjusted EPS fell 7.4% to $2.12 and adjusted EBITDA declined 5.4% to $149.8 million. Gross margin narrowed to about 34.2%. Full-year operating cash flow was nearly flat at $433.8 million, while Stride repurchased $188.7 million of shares.
TradingKey
Wed, Aug 5
CompX Q2 2026 Earnings: Margin Expansion Drives Faster Profit Growth
CompX International’s Q2 2026 net sales rose approximately 8.2% year over year to $43.6 million, while diluted EPS increased about 34.1% to $0.59. Operating income climbed approximately 41.3% to $8.9 million as gross profit grew faster than sales, supported mainly by Security Products and, to a lesser extent, Marine Components. Gross margin expanded to about 35.6% from 32.0%, while SG&A remained flat at $6.6 million. Higher demand across healthcare, transportation, tool storage and distributor markets was the quarter’s primary operating driver.
TradingKey
Wed, Aug 5
Navigator Gas Q2 2026 Earnings: Higher Freight Rates Lift Revenue and Profit
Navigator Gas reported Q2 2026 total operating revenue of $167.9 million, up 29.5% year over year, while diluted EPS increased to $0.85 from $0.31. Adjusted EBITDA rose 43.9% to $86.4 million as higher TCE rates, 90.8% fleet utilization and record throughput at the Morgan’s Point ethylene terminal offset fewer available vessel days. The quarter benefited from trade dislocations linked to Strait of Hormuz disruption, but management expects Q3 market conditions and terminal volumes to normalize. The planned $183 million Unigas divestiture and newbuild funding commitments now shape capital allocation.
TradingKey
Wed, Aug 5
Fuel Tech Q2 2026 Earnings: Revenue Rises 17% as Margins Contract
Fuel Tech’s Q2 2026 revenue increased 17% to $6.5 million, but diluted loss per share widened to $0.04 from $0.02 and net loss reached $1.2 million. Both APC and FUEL CHEM posted higher sales, while consolidated gross margin fell to 41% from 46% because of project mix, demonstration, freight, and maintenance labor costs. APC backlog was $14.3 million at June 30, and Fuel Tech held about $29.6 million in cash and investments with no debt, although six-month operating cash flow turned negative.
TradingKey
Wed, Aug 5
Crexendo Q2 2026 earnings: Service revenue drives 49% growth
Crexendo (CXDO) reported Q2 2026 revenue of $24.6 million, up 49% year over year, while GAAP diluted EPS fell to $0.03 from $0.04. Service revenue rose 78% to $14.9 million and supplied most of the company’s $8.1 million revenue increase. Non-GAAP net income and adjusted EBITDA each reached $4.1 million, but GAAP net income slipped to $1.1 million as operating expenses grew 53%. Cash and equivalents ended June at $18.3 million, down from $31.4 million at year-end 2025.
TradingKey
Wed, Aug 5
Centuri Q2 2026 earnings: Record revenue came with margin pressure
Centuri’s Q2 2026 revenue rose 32.9% to a record $962.0 million, while diluted EPS fell to $0.06 from $0.09. Gross profit increased only 2.0% to $69.1 million, and gross margin contracted to 7.2% from 9.4% as higher fuel costs, U.S. Gas mobilization spending, and a City of Chicago reversal offset broad-based segment growth. Adjusted EBITDA increased 5% to $75.7 million. The company also updated full-year guidance to include JJ White and additional fuel expense, while backlog reached $6.4 billion.
TradingKey
Wed, Aug 5
Grainger Q2 2026 earnings: Margin expansion supports a higher outlook
Grainger’s Q2 2026 net sales rose 10.3% to $5.021 billion, while diluted EPS increased 20.5% to $12.01. Gross margin expanded 100 basis points to 39.5%, helped materially by a $43 million IEEPA tariff refund, segment improvement, and the company’s U.K. market exit. Operating cash flow reached $444 million and free cash flow was $333 million. Grainger raised its full-year adjusted outlook, including net sales of $19.4 billion to $19.7 billion and diluted EPS of $45.50 to $47.25.
TradingKey
Wed, Aug 5
Lipocine Q2 2026 earnings: Missing license revenue drives top-line decline
Lipocine’s Q2 2026 revenue fell to $190,099 from $622,849 as the prior-year quarter included $500,000 of license revenue, while TLANDO royalty revenue rose to $190,099 from $122,849. Net loss widened to $2.6 million, although diluted loss per share narrowed to $0.32 from $0.41 as the weighted-average share count increased. Cash, equivalents and marketable securities reached $23.3 million. The quarter also followed LPCN 1154’s failure to meet its Phase 3 primary endpoint, making the planned FDA meeting and newly initiated placebo-controlled trial central next steps.
TradingKey
Wed, Aug 5
Harmony Biosciences Q2 2026 earnings: WAKIX revenue rises 30%
Harmony Biosciences reported Q2 2026 WAKIX net product revenue of $261.3 million, up 30% year over year, while diluted EPS rose to $1.28 from $0.68. Net income reached $75.4 million as revenue growth and lower operating expenses outweighed pressure from new Novitium royalties, which narrowed gross margin. The company reiterated full-year WAKIX revenue guidance of $1.0 billion to $1.04 billion and outlined upcoming BP-205 clinical milestones and the April 1, 2027 PDUFA target for pitolisant GR. The quarter combined commercial growth with a heavier product-cost burden.
TradingKey
Wed, Aug 5
Palvella Q2 2026 earnings: R&D spending widens loss as NDA advances
Palvella Therapeutics’ Q2 2026 net loss widened to $21.9 million from $9.5 million, while basic and diluted loss per share increased to $1.52 from $0.86. R&D expense rose to $12.5 million as the company funded manufacturing, angiokeratoma development, its rolling QTORIN rapamycin NDA and additional personnel. Palvella ended June with $250.6 million in cash, cash equivalents and short-term investments while maintaining plans to complete the NDA in the second half of 2026 and launch in the first half of 2027 if approved.
TradingKey
Wed, Aug 5
Thryv Q2 2026 Earnings: SaaS Mix Reaches 76% as Revenue Falls 28%
Thryv’s Q2 2026 revenue fell 28.4% year over year to $150.7 million, while diluted EPS swung to a $0.38 loss from $0.31 in earnings. SaaS revenue slipped 0.5% to $114.5 million but rose to 76% of total revenue as Marketing Services revenue dropped 62%. Adjusted EBITDA declined to $20.8 million, and Thryv announced a $20 million to $25 million restructuring plan targeting $55 million to $60 million in annualized gross savings. Full-year SaaS revenue guidance is $453 million to $457 million.
TradingKey
Wed, Aug 5
FIS Q2 2026 Earnings: Total Issuing Solutions Lifts Revenue and Margins
FIS reported Q2 2026 revenue of $3.377 billion, up 29% year over year, and GAAP diluted EPS of $0.45 versus a $0.90 loss. Adjusted EBITDA rose 35% to $1.409 billion as margin expanded 193 basis points to 41.7%, supported by Total Issuing Solutions, favorable mix, and cost savings. Free cash flow increased 220% to $525 million. However, pro forma revenue growth was 5.3%, and FIS lowered its full-year pro forma revenue and adjusted EBITDA growth ranges while raising its free cash flow target by $100 million.
TradingKey
Wed, Aug 5
Albany International Q2 2026 Earnings: Composites Drive Margin Expansion
Albany International reported Q2 2026 revenue of $329.5 million, up 6% year over year, while diluted GAAP EPS rose to $0.61 from $0.31. Adjusted EBITDA increased 11.5% to $57.8 million as Engineered Composites growth and a more profitable program mix outweighed Machine Clothing softness, equipment downtime, and currency pressure. Consolidated adjusted EBITDA margin expanded to 17.6%, but quarterly free cash flow turned negative as operating cash flow weakened, leaving cash conversion and working-capital trends central to the next quarter.
TradingKey
Wed, Aug 5
Featured Tools
Top News
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
Micron vs. SK Hynix: As HBM Demand Continues to Surge, Which Memory Stock Deserves More Attention?
Cerebras Cloud Revenue Nearly Quadrupled — But Why Did the Stock Crash 17% on "Confusing" GAAP Results?
Western Digital Shares Plunge 50%: Is It the Best Time to Buy?
